🔎 Trials Near Me

Beranda › Penyakit Crohn › North Carolina › Durham

Uji klinis Penyakit Crohn di Durham, NC

12 studi untuk Penyakit Crohn mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Menerima pesertaFase 3
  • University of North Carolina Medical Center ( Site 5034), Chapel Hill · 10 mi jauhnya
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06430801

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 2/3
  • University of North Carolina, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Duke University Medical Center-Site Number: 8400093, Durham
  • UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi jauhnya
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074, Chapel Hill · 10 mi jauhnya
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184944

A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically

Menerima pesertaFase 4
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Wanita · Diperbarui 28 Agu 2026 · NCT07654751

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • University of North Carolina Hospital, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07577843

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Menerima pesertaStudi observasional
  • University of North Carolina, Chapel Hill · 10 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07237516

Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)

Menerima peserta
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 18 hingga 44 · Wanita · Diperbarui 14 Jul 2026 · NCT07337902

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Menerima pesertaFase 3
  • Univ NC Chapel Hill /ID# 262198, Chapel Hill · 10 mi jauhnya
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Jun 2026 · NCT06332534

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Menerima pesertaStudi observasional
  • Duke Health System, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 17 Apr 2026 · NCT07198113

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Menerima pesertaFase 2
  • Investigational Site Number: 8400003, Chapel Hill · 10 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06958536

Uji klinis Penyakit Crohn di kota lain

Studi lain di Durham

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.